The HRP-conjugated TP53INP2 antibody is a polyclonal rabbit IgG antibody designed to target specific epitopes within the human TP53INP2 protein. It is widely used to study TP53INP2’s roles in autophagy, cancer progression, and transcriptional regulation. Key features include:
Conjugate: Horseradish peroxidase (HRP) for enzymatic signal amplification.
Immunogen: Recombinant human TP53INP2 protein (residues 100–220; UniProt ID: Q8IXH6) .
Host Species: Rabbit.
Reactivities: Human (primary), with cross-reactivity reported in mouse and rat in some formulations .
Autophagosome Formation: TP53INP2 interacts with LC3-related proteins (e.g., GABARAP) and VMP1 to scaffold autophagosome membranes, a mechanism confirmed via coimmunoprecipitation studies .
Cancer Progression:
Immunohistochemistry: Used to identify elevated TP53INP2 levels in 62.5% of bladder cancer tissues compared to 25% in adjacent non-tumor tissues (p < 0.05) .
ELISA: Validated for quantitative analysis with recommended dilutions of 0.2–1 µg/mL in western blotting .
Nuclear-to-cytoplasmic translocation of TP53INP2 under autophagy induction requires careful subcellular localization analysis .
Cross-reactivity with mouse/rat tissues necessitates validation for non-human studies .